This report aims to provide detailed insights into the global Apoptosis Assays Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.
Expected Revenue Growth: This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
Download PDF Brochure:
By product, the Assay kits segment is expected to account for the largest share of the apoptosis assays market in 2018
On the basis of product, assay kits segment is expected to account for the largest share of the apoptosis assays market in 2018. Assay kits are widely used in life sciences research, drug discovery and development, and environmental monitoring in a broad range of applications such as studying disease pathways, screening for potential drug candidates, and evaluating biopharmaceutical production processes. This large share can be attributed to the repeated consumption of assay kits as consumables in various apoptosis testing processes.
By application, the drug discovery & development application segment is projected to have the largest market share during the forecast period (2018-2023)”
Based on application, the apoptosis assays market is segmented into drug discovery & development, clinical & diagnostic applications, basic research, and stem cell research. In 2018, the drug discovery & development application segment is expected to account for the largest share of the global apoptosis assays market. The large share of this segment can be attributed to the rising incidence and prevalence of chronic and infectious diseases and increasing government support for developing new treatments for various human diseases.
By end user, the pharmaceutical and biotechnology companies segment is is projected to have the largest market share during the forecast period (2018-2023)”
On the basis of end user, the apoptosis assays market is segmented into pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, and academic and research institutes. The pharmaceutical and biotechnology companies segment is expected to account for the largest share in 2018. The large share of this segment can be attributed to the increasing number of R&D activities undertaken by these companies for the development of biopharmaceutical products.
North America to dominate the market in 2018
North America is expected to account for the largest share of the apoptosis assays market in 2018, followed by Europe and Asia Pacific. The rising incidence and prevalence of chronic and infectious diseases, a large number of life science research studies conducted in the region, favorable government support in the form of research investments, and presence of high-quality infrastructure for clinical and laboratory research are the major factors responsible for the large share of the North American apoptosis assays market.
Objectives of the Study
To define, describe, segment, and forecast of the global apoptosis assays industry by product, application, detection technology, end user, and region
To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast the size of the apoptosis assays market in five main regions (along with major countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa
To profile key players in the global apoptosis assays market and comprehensively analyze their core competencies and market shares
To track and analyze competitive developments such as mergers and acquisitions; new product/technology launches; expansions; collaborations and agreements; and R&D activities of the leading players in the global apoptosis assays market
Request Sample Report:
Key Market Player
The prominent players in the global apoptosis assays market are Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), Danaher Corporation (US), Becton, Dickinson and Company (US),Sartorius AG (Germany), Geno Technology (US), GeneCopoeia, Inc. (US), Bio-Techne Corporation(US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), and Creative Bioarray (US).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441